Advanced identification of the gene mutations causing epilepsy syndromes is expected to
translate into faster diagnosis and more effective treatment of these conditions. Over the last …

Seizures are the most distinctive and frequent manifestations of neurological disease in the
neonatal period. Compared with seizures in older patients, neonatal seizures have different …

Background Evidence-based data on treatment of neonatal status epilepticus (SE) are
scarce. We aimed to collect data on the efficacy and safety of ketamine for the treatment of …

Hypoxic-ischemic encephalopathy (HIE) is the most common cause of neonatal seizures. 1
Seizures in neonates with HIE peak in the first days after birth and are often subclinical. 1 …

Background Lacosamide is an antiepileptic drug with US Food and Drug Administration
approval for the treatment of partial-onset seizures in patients older than one month …

The genomic revolution has resulted in the discovery of hundreds of genetic etiologies for a
variety of epilepsies and allowed science to probe the mechanisms of acquired epilepsies …

Neonatal seizures are relatively common, but their diagnosis and management remain
challenging. We reviewed the scientific literature on neonatal seizures from July 1973 to …

Objective This study aimed to assess the viability of implementing a tele-educational training
program in neurocritical care for newborns diagnosed with hypoxic–ischemic …

The neurotransmitter GABA is normally characterized as having an inhibitory effect on
neural activity in the adult central nervous system (CNS), which quells over-excitation and …

Several studies have shown that antibiotics, analgesic–sedative, and antiseizure
medications are among the most commonly used medications in preterm and sick neonates …